—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Madrigal Pharmaceuticals Inc (MDGL) — Technical state

As of 2026-11-03 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 39 out of 100 (momentum 32 · quality 23 · valuation 14), as of 2026-11-04.
  • Signal: Downtrend stack — Trades -19.9% vs the 50-day and -20.6% vs the 200-day average, 35.6% below the 52-week high and +2.3% off the 52-week low; a death cross printed 3 sessions ago. Computed from daily closes. (as of 2026-11-03)
  • Trend: Madrigal Pharmaceuticals Inc trades 19.9% below its 50-day and 20.6% below its 200-day moving average. (as of 2026-11-03)

Madrigal Pharmaceuticals is a biopharmaceutical company that develops treatments for metabolic dysfunction-associated steatohepatitis, a liver disease often called MASH. Its lead product, Rezdiffra, works by activating a thyroid hormone receptor in the liver to reduce fat build-up.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the MDGL overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Downtrend stack

Trades -19.9% vs the 50-day and -20.6% vs the 200-day average, 35.6% below the 52-week high and +2.3% off the 52-week low; a death cross printed 3 sessions ago. Computed from daily closes.

The moving-average stack

Continue: the MDGL chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-03

Quick answers

What is the current Closelooknet signal on MDGL?

Downtrend stack — Trades -19.9% vs the 50-day and -20.6% vs the 200-day average, 35.6% below the 52-week high and +2.3% off the 52-week low; a death cross printed 3 sessions ago. Computed from daily closes. As of 2026-11-03; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is MDGL above its 50-day and 200-day moving averages?

As of 2026-11-03, Madrigal Pharmaceuticals Inc trades -19.9% below its 50-day and -20.6% below its 200-day average, with the 20-day -11.8% away.

How far is MDGL from its 52-week high?

35.6% below the 52-week high and 2.3% above the 52-week low, as of 2026-11-03.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.